Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
8th grade Avg
|
|
New words:
abandon, acclimate, acid, Addendum, additio, addtion, Aigner, Annicken, app, attended, attract, attracting, Bermuda, Biogal, Bluebird, Bulgaria, Cardinal, charter, Chlortetracyline, civi, cluded, CMS, concomitant, containingchlortetracyclineused, Contruction, corn, costly, Crop, cting, cu, Dean, derecognition, deter, dispute, Dumex, een, Endo, ETR, Expert, Fabrik, fac, fashion, forKADIAN, freedom, freezing, froze, Fuzhou, gap, genericcompetition, genericproduct, genericsubsidiary, GP, Guilford, Hatch, Henriette, HHS, Hisun, hit, HRSA, ility, infrastructure, Ingersoll, inquiry, insignificant, Inspirion, jury, King, KKJ, LEK, levied, liab, liabilit, Livzon, MGI, Mitchell, MMA, mupirocin, Nippon, noncurrent, ntinuing, opera, opioid, Orange, outbreak, outlined, overage, passage, PDL, Pennfield, pharmacokinetic, Pioneed, pivotal, proc, quorum, Rand, ratably, recommend, redundant, reevaluating, refle, Reliant, relocation, roduct, Romania, roval, Scholastic, sk, skilled, slight, sodium, SPAP, Stefan, steroid, subcaption, Swekk, synthesized, teicoplanin, territory, thereon, Turkey, unrecognized, unremitted, Usage, VA, vel, verdict, VHCA, vi, vivo, Waxman, wrap, xpected, Yanghen, ystem
Removed:
accretion, achievement, Agent, ago, alter, APB, arrangement, Asian, backlog, Banc, bid, bridge, British, calculate, cast, CIBC, clarify, closed, Cohen, compete, conflict, consolidate, consolidating, conversion, convert, corrective, covenant, cured, dedicated, deducting, discontinuation, distributor, divestiture, EBITDA, encountered, excluded, family, Farah, fix, French, frequently, Graph, guaranty, Haute, idle, inception, inclusion, Indenture, influence, involving, ivax, Joinder, jointly, Kurt, leadership, learning, legally, leverage, lowering, mail, meaningful, mentioned, Michael, Nestor, newly, nonguarantor, Nopal, offering, Orlofski, owner, planned, ratification, refinancing, reflecting, rendered, restrictive, restructuring, Roy, SAS, sensitive, shelf, Skoyen, Stier, structure, technological, Terre, traded, ts, twenty, unaffiliated, unconditionally, undistributed, unsecured, vendor, Wachovia, waiver, warehouse, William, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 3.2 Amended and Restated By-laws of the Company
- 10.1 Amended and Restated Loan and Security Agreement
- 10.1 Amended and Restated Loan and Security Agreement
- 10.5 Agreement on the Succession of Pension Obligations
- 10.12 Separation Agreement
- 10.25 Amendment Agreement
- 10.27 Amendment No. 1 to the 2003 Omnibus Incentive Comp. Plan
- 10.27 Amendment No. 2 to the 2003 Omnibus Incentive Comp. Plan
- 10.27 Amendment No. 3 to the 2003 Omnibus Incentive Comp. Plan
- 10.28 Amended Alpharma Inc. Executive Bonus Plan
- 10.29 AMENDMENT-1997 Incentive Stock Option and Appreciation Right Plan
- 10.29 AMENDMENT-1997 Incentive Stock Option and Appreciation Right Plan
- 10.31 2005 Supplemental Savings Plan
- 10.31 Amendment - 2005 Supplemental Savings Plan
- 10.31 Amendment No. 1 Supplemental Savings Plan
- 10.32 2007 Supplemental Savings Plan
- 10.37 Severance Plan Amended and Restated
- 10.38 Change In Control Plan
- 10.39 Amendment to the Deferred Compensation Plan
- 10.40 A.l. Pharma Inc. Supplemental Pension Plan
- 10.40 Amendment No. 1 - A.l. Pharma Supplemental Pension Plan
- 10.40 Amendment No. 2 - Alpharma Inc. Supplemental Pension Plan
- 10.41 Non-employee Director Option Plan
- 10.41 Amendment to the Non-employee Director Option Plan
- 10.42 Supplemental Savings Plan
- 10.42 Amendment No. 1 Supplemental Savings Plan
- 10.42 Amendment No. 2 Supplemental Savings Plan
- 21 List of Subsidiaries
- 23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 Consent of Bdo Seidman LLP
- 31 Certification - Section 302
- 31 Certification - Section 302
- 32 Certification - Section 906
Related press release
Alpharma similar filings
Filing view
External links